Zucker School of Medicine at Hofstra/Northwell (North Shore University Hospital/LIJ)
Infectious Disease fellowship · Manhasset, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Donald & Barbara Zucker School of Medicine at Hofstra/Northwell's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About Donald & Barbara Zucker School of Medicine at Hofstra/Northwellinstitution-wide infectious disease research
Infectious Disease publications from Donald & Barbara Zucker School of Medicine at Hofstra/Northwell + Northwell Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
54
works per year
36th of 71 infectious disease fellowship programs
-48.3%
2-year growth
61st of 71 infectious disease fellowship programs
13.0%
in top 10% of field (works before 2025)
59th of 67 infectious disease fellowship programs
32.1%
cited above world average
59th of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 251
Infectious Disease research topics at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Papers in the window; each links to the list on OpenAlex.
- COVID-19 Clinical Research Studies 94
- SARS-CoV-2 and COVID-19 Research 37
- Antifungal resistance and susceptibility 19
- HIV/AIDS Research and Interventions 15
- Clostridium difficile and Clostridium perfringens research 13
- Antimicrobial Resistance in Staphylococcus 10
- Otolaryngology and Infectious Diseases 10
- Infection Control in Healthcare 9
Most cited at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell since 2024
All infectious disease papers there on OpenAlex
- 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman et al. · Journal of Thrombosis and Haemostasis · 2024 · PubMed · cited 47
- Influenza-Associated Acute Necrotizing Encephalopathy in US ChildrenInfluenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group et al. · JAMA · 2025 · PubMed · cited 38
- Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Avina Vongpradith et al. · The Lancet Infectious Diseases · 2026 · PubMed · cited 23
- Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan AreaNgan M. Nguyen et al. · AIDS Patient Care and STDs · 2024 · PubMed · cited 21
- Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park et al. · JCI Insight · 2024 · PubMed · cited 13
- Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohortsShannon W. Wuller et al. · PLoS ONE · 2025 · PubMed · cited 12
- At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methodsMunib Mesinovic et al. · Scientific Reports · 2024 · PubMed · cited 12
- COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With CancerJacek Skarbinski et al. · JAMA Oncology · 2025 · PubMed · cited 11
- Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseasesErik Anderson et al. · JCI Insight · 2024 · PubMed · cited 11
- Fecal microbiota transplantation as a therapeutic modality for recurrent Clostridioides difficile infection: reviewing efficacy, safety, mechanisms of action, and outcomesChukwuka Elendu et al. · Annals of Medicine and Surgery · 2025 · PubMed · cited 9